Company news

PolyNovo Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

AGM - Chairman and CEO address to shareholders

November 3, 2023

BARDA increases funding US$10M

October 1, 2023

YTD August 2023 Trading Update

September 25, 2023

FY23 Results Presentation

August 23, 2023

Appendix 4E and FY23 Financial Statements

August 23, 2023

First ever A$7M Sales Month

June 6, 2023

NovoSorb MTX First Sales and March 2023 $6m Revenue

May 2, 2023

S&P DJI Announces March 2023 Quarterly Rebalance

March 3, 2023

1H FY23 Results Presentation

February 22, 2023

Appendix 4D and 1H FY23 Report

February 22, 2023

1H23 Indicative Trading Result (unaudited)

January 15, 2023

Successful Completion of Share Purchase Plan

December 16, 2022

Share Purchase Plan (SPP) Offer

November 29, 2022

Completion of $30m Institutional Placement

November 22, 2022

Capital Raising

November 22, 2022

Investor Presentation

November 22, 2022

Chairman and CEO - AGM address to shareholders

October 28, 2022

Q1 FY23 Sales Result

October 5, 2022

FDA 510(k) clearance for NovoSorb MTX

September 18, 2022

Trading halt

September 16, 2022

Pause in trading

September 16, 2022

PolyNovo FY22 Briefing Session

August 26, 2022

FY22 Results Presentation

August 26, 2022

Appendix 4E and FY22 Financial Statements

August 26, 2022

First Patient enrolled - SynPath Diabetic Foot Ulcer Trial

August 10, 2022

CEO Appointment - Swami Raote

July 29, 2022

S&P DJI Announces June 2022 Quarterly Rebalance

June 3, 2022

Trading Update Q3 FY22

April 6, 2022

Appendix 4D and 1H FY22 Report

February 24, 2022

1H FY22 Results Presentation

February 24, 2022

1H22 Indicative Trading Result (unaudited)

January 10, 2022

Record US sales in July and Nov, and other matters

December 13, 2021

Managing Director resignation

November 5, 2021

Q1 FY22 Trading Update - Clarification Announcement

October 29, 2021

Chairman and Managing Director - AGM address

October 26, 2021

COVID Trading Themes - Q1 FY22 Update

October 20, 2021

First patient enrolled in Pivotal Trial - BARDA

September 21, 2021

FY21 Results Presentation

August 26, 2021

Appendix 4E and FY21 Financial Statements

August 26, 2021

FY21 BTM Revenue Results

July 12, 2021

PolyNovo signs with Premier Inc. (GPO)

March 25, 2021

Distributor App. - PolyNovo enters Denmark, Norway & Iceland

February 24, 2021

H1 FY21 Results Investor Presentation

February 22, 2021

Appendix 4D and H1 FY21 Report

February 22, 2021

PolyNovo enters Italy - Distributor Appointment

February 1, 2021

PolyNovo enters Turkey - Distributor Appointment

January 19, 2021

PolyNovo enters Poland - Distributor Appointment

January 19, 2021

Response to ASX Query

January 17, 2021

Trading Update - H1 FY21

January 11, 2021

PolyNovo enters Belgium, Netherlands, Luxemburg & Sweden

November 18, 2020

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 36 decks. Every deck is listed under its year.